Showing results (341-350 of 686) with videos related to

Sort By:
Pageof 69
British Journal of Cancer|September 1, 1995
Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometryN Feller, C M Kuiper, J Lankelma, et al.
Journal of Chromatography|August 3, 1990
Sensitive method for the determination of daunorubicin and all its known metabolites in plasma and heart by high-performance liquid chromatography with fluorescence detectionJ de Jong, P A Maessen, A Akkerdaas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Cancer Treatment Reports|March 1, 1984
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatinJ B Vermorken, W J van der Vijgh, I Klein, et al.
The New England Journal of Medicine|October 8, 1981
Quality of institutional participation in multicenter clinical trialsR J Sylvester, H M Pinedo, M De Pauw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Altered pharmacokinetics and metabolism of CPT-11 in liver dysfunction: a need for guidelinesC J van Groeningen, W J Van der Vijgh, J J Baars, et al.
International Journal of Cancer|May 29, 1995
Addition of leucovorin in modulation of 5-fluorouracil with methotrexate: potentiating or reversing effect?C L Van der Wilt, B J Braakhuis, H M Pinedo, et al.
Biochemical Pharmacology|September 1, 1988
DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effectsG Schwartsmann, G J Peters, E Laurensse, et al.
Investigational New Drugs|January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)E E Holdener, H H Hansen, H Høst, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 19, 2016
High intensity smoking cessation interventions: Cardiac patients of low socioeconomic status and low intention to quit profit mostN Berndt, H de Vries, L Lechner, et al.
Pageof 69